GENEVA, Aug. 17 -- DALIAN WANCHUNBULIN PHARMACEUTICAL CO., LTD. (No. 19-6 DD4 Street, Dalian Economic & Technological Development ZoneDalian, Liaoning 116620), 大连万春布林医药有限公司 (中国辽宁省大连市大连经济技术开发区双D4街19号-6) filed a patent application (PCT/CN2025/075832) for "USE OF COMBINATION OF PLINABULIN, PEMBROLIZUMAB, AND DOCETAXEL" on Feb 05, 2025. With publication no. WO/2025/167924, the details related to the patent application was published on Aug 14, 2025.
Notably, the patent application was submitted under the International Patent...